Brian Aidan McCaul

QUBIS Ltd (Qubis) is a venture capital firm, subsidiary of Queen's University of Belfast founded in the year 1984. The firm is headquartered in Belfast, Northern Ireland.

Aerogistics Holdings Ltd. provides aerospace logistics services. It offers supply chain management services through its subsidiaries Aerogistics Ltd. and King & Fowler Ltd. The company was founded by Tom Dawes in 2004 and is headquartered in Liverpool, UK.

Knowledge Transfer Partnerships is a non-profit organization that helps businesses improve their competitiveness and productivity by utilizing knowledge, technology, and skills. The private company is based in Didcot, UK.

SpermComet Ltd. provides fertility testing for men. It provides treatment for miscarriage, infertility and the spermComet test. The company was founded by Sheena Elizabeth M. Lewis in 1995 and is headquartered in Belfast, the United Kingdom.

Aimes Grid Services Community Interest Co. is a cloud solutions and services provider that has been delivering innovative solutions to customers for over 10 years. Aimes is based in Liverpool, UK. The British company has developed a unique skillset in the healthcare and health data research communities, providing intelligent data solutions. The private company is involved in several projects, including the development of an AI Precision Diagnostics Tool for Cardiovascular Care, a secure platform for the provision of virtual desktops to NHS workers, and the design and development of an AI system that can predict early onset of mental health crisis for clinicians to review and act upon where necessary. The company also provides a multi-level support service for their cloud infrastructure and offer flexible and competitive HSCN services to enable connectivity between health and social care customers.

Re-Vana Therapeutics Ltd. is a specialty ocular therapeutic and British drug delivery company that focuses on developing its internal pipeline and external strategic collaborations to advance its novel drug delivery platform. In 2022, Re-Vana won the Ophthalmic Innovation Summit Retina Award in drug delivery and the Belfast Nth Ireland Chamber 2022 Award for Business Innovation. Re-Vana Therapeutics was founded in 2016 as a spin-out from Queen's University, with the main office located in Belfast, UK, and an office, Re-Vana Therapeutics, Inc., based elsewhere. The company has raised more than $17.75m to support the development of sustained release biologics. In 2019, Re-Vana secured funding from Innovate totaling more than $400k to support the development of a sustained release drug. Additionally, in 2020, the company entered into a strategic feasibility collaboration with a leading pharmaceutical company for a novel therapeutic.